TY  - JOUR
AU  - Mezquita-Raya, Pedro
AU  - Ramírez de Arellano, Antonio
AU  - Kragh, Nana
AU  - Vega-Hernandez, Gabriela
AU  - Pöhlmann, Johannes
AU  - Valentine, William J
AU  - Hunt, Barnaby
PY  - 2017
DO  - 10.1007/s13300-017-0239-6
SN  - 1869-6953
UR  - http://hdl.handle.net/10668/10890
T2  - Diabetes therapy : research, treatment and education of diabetes and related disorders
AB  - Glucagon-like peptide-1 (GLP-1) receptor agonists are used successfully in the treatment of patients with type 2 diabetes as they are associated with low hypoglycemia rates, weight loss and improved glycemic control. This study compared, in the...
LA  - en
KW  - Cost
KW  - Cost-effectiveness
KW  - Diabetes mellitus
KW  - Liraglutide
KW  - Lixisenatide
KW  - Spain
TI  - Liraglutide Versus Lixisenatide: Long-Term Cost-Effectiveness of GLP-1 Receptor Agonist Therapy for the Treatment of Type 2 Diabetes in Spain.
TY  - research article
VL  - 8
ER  -